Cavitation Technologies (CVAT) Liabilities and Shareholders Equity (2011 - 2026)

Cavitation Technologies (CVAT) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $66000.0 in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 88.54% year-over-year to $66000.0; the trailing twelve-month figure through Mar 2026 stood at $478000.0 (down 70.48% YoY), and the FY2025 full-year result was $297000.0, up 19.76% from the prior year.
• Liabilities and Shareholders Equity advanced to $66000.0 in Q1 2026, from $55000.0 in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 million in Q1 2022 to a low of $55000.0 in Q4 2025.
• A 5-year average of $721294.1 and a median of $275000.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity slumped 94.25% in 2023 and soared 647.92% in 2024, its largest moves.
• Tracing CVAT's Liabilities and Shareholders Equity over 5 years: stood at $1.7 million in 2022, then tumbled by 94.25% to $96000.0 in 2023, then soared by 647.92% to $718000.0 in 2024, then tumbled by 92.34% to $55000.0 in 2025, then climbed by 20.0% to $66000.0 in 2026.
• Business Quant data shows CVAT's Liabilities and Shareholders Equity at $66000.0 in Q1 2026, $55000.0 in Q4 2025, and $60000.0 in Q3 2025.